Concepedia

Julie Schanz

JS

Statistics

Publications

32

Citations

6.7K

H-Index

22

Active since

1999

Affiliations

University of Göttingen(Current)

Heinrich Heine University Düsseldorf

Medical University of Vienna

University of Freiburg

Hanusch Hospital

Julie Schanz is an author at University of Göttingen specializing in myelodysplastic syndromes, hematology, and molecular cytogenetics.

ORCID

Publications per year

1999–2022

32

Publications

32

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text

, , +12

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Detlef Haase, Ulrich Germing, Julie Schanz et al. · Blood · 2007 · 789 citations · Full text

, , +16

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

Julie Schanz, Heinz Tüchler, Françesc Solé et al. · Journal of Clinical Oncology · 2012 · 691 citations · Full text

, , +17

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian et al. · Nature Medicine · 2020 · 636 citations · Full text

, , +14

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Peter Valent, Attilio Orazi, David P. Steensma et al. · Oncotarget · 2017 · 189 citations · Full text

, , +15

1–5 of 32